TO THE EDITOR
The new WHO classification of lymphomas recognizes four clinical settings of immunodeficiency associated with an increased incidence of lymphoma and other lymphoproliferative disorders: (1) primary immune disorders; (2) HIV infection; (3) iatrogenic immunosuppression after solid organ or bone marrow transplantation; and (4) iatrogenic immunosuppression due to methotrexate treatment. 1 We describe three patients with an EBV-related lymphoproliferative disorder (LPD) without known underlying primary or secondary immune disorder, and suggest that EBV-related LPDs may occur more frequently than expected.
The first patient was a 34-year-old woman from Turkish ancestry. Her medical history revealed an autoimmune hemolytic anemia during her pregnancies in 1995 and 1997. In April 2002, she presented with fever, malaise and weight loss. Physical examination revealed a hepatosplenomegaly without lymphadenopathy. Biochemical analysis of the blood showed a pancytopenia with normal differential WBC and a markedly elevated LDH of 1348 U/l (normal value o450 U/l). ANA and ANCA were negative, EBV-IgG was 64 reciprocals of dilution, EBV-IgM was negative, and HIV was negative. The qualitative PCR for EBV performed on the whole blood was positive. CT scan showed pleural effusion, hepatosplenomegaly, and ascites. Bone marrow biopsy revealed interstitial infiltration with large polymorphic B-lymphocytes, partly with striking plasmacytic differentiation, classified as diffuse large B-cell lymphoma (Figure 1a) . Immunophenotyping with CD45 and CD20 were positive, CD79a and CD30 were heterogeneously positive. EBER (EBV-encoded small nonpolyadenylated RNAs) in situ hybridization was performed because of the unusual histology, and proved to be positive in the atypical cells. We were not able to assess reliable immunoglobulin expression in this decalcified paraffin-embedded material. The patient received eight courses of CHOP in combination with four courses of Rituximab (anti-CD20 antibodies). Her constitutional symptoms disappeared. Bone marrow histology and qualitative PCR for EBV became negative; however, the spleen remained slightly enlarged (diameter 13 cm). At 6 months after completion of treatment, this response is still ongoing.
The second patient was a 57-year-old woman, with a history of hypertension and diabetes mellitus type II. She presented with multiple enlarged lymph nodes in the neck region. She had no constitutional symptoms. Peripheral blood counts and LDH were normal. EBV-IgG was 256 reciprocals of dilution, EBV-IgM and HIV were negative. Bone marrow biopsy was negative. Lymph node biopsy showed an EBV-positive very polymorphic diffuse large B-cell lymphoma with similar histology and phenotype as the first patient, again with an unusual plasmacytic differentiation. Immunofluorescence for immunoglobulin was negative. She showed a complete response after six courses of conventional polychemotherapy without anti-CD20 antibodies. At this time, radiotherapy is given for the initially bulky localization in the neck.
The third patient was a 69-year-old woman of Chinese ancestry. Apart from diabetes mellitus type II with macrovascular complications, she had no medical history. She presented with fever, diarrhea, abdominal pain and weight loss. Biochemical analysis of the blood showed an autoimmune hemolytic anemia due to cold agglutinins IgM anti-I, with an elevated LDH of 1034 U/l. Serologic analysis showed that she was seronegative for HIV and HTLV-1, and also ANA and ANCA were negative. The IgG anti-EBV titer was 32 reciprocals of dilution; IgM anti-EBV was negative. Qualitative PCR analysis of EBV in peripheral blood was negative. A bone marrow biopsy revealed no abnormalities. Colonoscopy revealed multiple ulcerating lesions in the sigmoid colon (Figure 1b) . Pathologic analysis of biopsies from one of these lesions showed large atypical lymphoid cells with strong plasma cell differentiation (Figure 1c ). The cells were positive for CD79A, but only partially for CD20, and were negative for CD30 and LMP-1 (EBV-encoded latent membrane protein). There was a striking polyclonality for kappa and lambda. Many of the atypical cells were positive for EBER in situ hybridization (Figure 1d ). During her hospital stay, she developed upper gastrointestinal bleeding complicated by myocardial infarction. Due to her bad clinical condition, she was no candidate for intensive chemotherapy. She died 6 weeks after diagnosis.
In younger patients, such as the first patient, EBV-associated LPDs are associated with a variety of primary immunodeficient states such as congenital immunodeficiency and autoimmune lymphoproliferative syndrome. 1, 2 In middle-aged and elderly patients, such as the second and third patients, respectively, acquired immunodeficient states due to, for example, AIDS or immunosuppressive drugs are more likely to be causative. 3, 4 However, in a recent paper, several cases of very elderly patients with EBV-related LPD in the absence of immunodeficiency were presented. 5 In our patients of different age groups, no immunodeficiency could be detected. The three presented cases indicate that EBV-related LPDs occur more frequently than currently recognized. We suggest that in all cases of B-cell lymphomas with unusual histological features reminiscent of post-transplant lymphoproliferative disorders, an EBER in situ hybridization should be performed. Analogous to the post-transplant lymphoproliferative disorders, the diagnosis of EBV-related LPD may have important therapeutic consequences. Further studies are required to identify the surplus value of cytotoxic chemotherapy in combination with anti-CD20 antibodies. Strikingly, two patients suffered from autoimmune phenomena. It is unclear whether this occurred by chance or whether this forms a clue to the etiology of these lymphomas. In conclusion, the three presented cases demonstrate that EBV-related B-cell lymphomas can occur in both young and old patients without detectable underlying immunodeficiency. In cases where the original donor is not available or in whom autologous hematopoietic stem cells could not be collected prior to the transplant, cord blood may provide a rapidly available source of hematopoietic progenitor cells. 4 However, long-term complications following cord blood transplant in this setting are largely unknown. Here we describe two patients who received unrelated umbilical cord blood (UCB) stem cell transplants as salvage therapy after rejection of the first HSCT.
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Case report #1
A 38-year-old patient with chronic myeloid leukemia (CML) in blastic crisis underwent a haploidentical sibling peripheral blood stem cell transplant. The conditioning regimen included cyclophosphamide 60 mg/kg Â 2 days, thiotepa 5 mg/kg Â 1 day, total body irradiation (TBI) 300cGy Â 4 days and antithymocyte globulin (ATG) 15 mg/kg Â 2days.
Despite initial complete cytogenetic and hematologic remission and recovery of an absolute neutrophil count (ANC) of 0.5 Â 10 9 /l and platelet count of 420 Â 10 9 /l on days þ 10 and 
